Association between lipoprotein(a) and oxygen reactive metabolite in asymptomatic subjects

Polskie Archiwum Medycyny Wewnetrznej

Volumn 121, Issue 7-8, 2011, Pages 247-252

  Kotani, Kazuhiko ^a,b   Sakane, Naoki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Hypercholesterolemia; Lipoprotein(a); Oxidative stress; Reactive oxygen reaction

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 80052389421     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1067     Document Type: Article

References (28)

1. Marcovina S.M., Koschinski M.L. Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol. 1998; 82: 57U-66U. (Pubitemid 29047617)
2. Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009; 302: 412-423.
3. Galvano F., Malaguarnera M., Vacante M., et al. The physiopathology of lipoprotein (a). Front Biosci. 2010; 2: 866-875.
4. Harpel P.C., Gordon B.R., Parker T.S. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A. 1989; 86: 3847-3851. (Pubitemid 19141842)
5. Koschinsky M.L. Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein. Curr Atheroscler Rep. 2005; 7: 389-395. (Pubitemid 41684214)
6. Beisiegel U., Niendorf A., Wolf K., et al. Lipoprotein(a) in the arterial wall. Eur Heart J. 1990; 11 Suppl: E174-E183
7. Nielsen L.B. Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: Insight from in vivo studies of arterial wall influx, degradation and efflux. Atherosclerosis. 1999; 143: 229-243. (Pubitemid 29166903)
8. Sotiriou S.N., Orlova V.V., Al-Fakhri N., et al. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J. 2006; 20: 559-561. (Pubitemid 46671249)
9. Stephens J.W., Bain S.C., Humphries S.E. Gene-environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis. 2008; 200: 229-238.
10. Rizzo M., Kotur-Stevuljevic J., Berneis K., et al. Atherogenic dyslipidemia and oxidative stress: A new look. Transl Res. 2009; 153: 217-223.
11. Szułdrzyński K., Zalewski J., Machnik A., et al. Elevated levels of 8-iso-prostaglandin F2α in acute coronary syndromes are associated with systemic and local platelet activation. Pol Arch Med Wewn. 2010; 120: 19-24.
12. Galle J., Schneider R., Heinloth A., et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress. Kidney Int. 1999; 55: 1450-1461. (Pubitemid 29157144)
13. Tsimikas S., Kiechl S., Willeit J., et al. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: Five-year prospective results from the Bruneck study. J Am Coll Cardiol. 2006; 47: 2219-2228. (Pubitemid 43795077)
14. Bergmark C., Dewan A., Orsoni A., et al. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res. 2008; 49: 2230-2239.
15. Inoue N. Vascular C-reactive protein in the pathogenesis of coronary artery disease: Role of vascular inflammation and oxidative stress. Cardiovasc Hematol Disord Drug Targets. 2006; 6: 227-231. (Pubitemid 44890585)
16. Hulsmans M., Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med. 2010; 14: 70-78.
17. Yoshida A., Matsutani Y., Fukuchi Y., et al. Analysis of the factors contributing to serum retinol binding protein and transthyretin levels in Japanese adults. J Atheroscler Thromb. 2006; 13: 209-215.
18. Pirinccioglu A.G., Gökalp D., Pirinccioglu M., et al. Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clin Biochem. 2010; 43: 1220-1224.
19. Iamele L., Fiocchi R., Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med. 2002; 40: 673-676. (Pubitemid 34982475)
20. Vassalle C. An easy and reliable automated method to estimate oxidative stress in the clinical setting. Methods Mol Biol. 2008; 477: 31-39.
21. Vassalle C., Pratali L., Boni C., et al. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease. Clin Biochem. 2008; 41: 1162-1167.
22. Kotani K., Koibuchi H., Miyamoto M., et al. Relationship between reactive oxygen metabolites and carotid intima-media thickness in subjects with hypercholesterolemia. Med Princ Pract. 2010; 19: 496-498.
23. Sugiuchi H., Irie T., Uji Y., et al. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate. Clin Chem. 1998; 44: 522-531. (Pubitemid 28141347)
24. Gaw A., Gourlay C.W., Brown E.A., Bell M.A. Evaluation of a new automated latex agglutination assay for lipoprotein(a): Comparison with a manual ELISA. Clin Chim Acta. 1997; 261: 175-183. (Pubitemid 27214575)
25. Gotoh T., Kuroda T., Yamasawa M., et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol. 1995; 76: 928-932.
26. Hirose H., Kawabe H., Komiya N., Saito I. Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb. 2009; 16: 77-82.
27. Pati U., Pati N. Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism. Mol Genet Metab. 2000; 71: 87-92.
28. Cardoso-Saldaña G., De La Peña-Díaz A., Zamora-González J., et al. Ethnicity and lipoprotein(a) polymorphism in Native Mexican populations. Ann Hum Biol. 2006; 33: 202-212.